Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
September 23, 2011
Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma
Beth Woods, Noman Paracha, David A Scott, et al.
BMC Medical Research Methodology
|
May 23, 2021
Classifying information-sharing methods
Georgios F Nikolaidis, Beth Woods, Stephen Palmer, et al.
Health Economics
|
January 16, 2024
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required
Beth Woods, James Lomas, Mark Sculpher, et al.
Journal of Medical Economics
|
December 7, 2013
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales
Sarah Dewilde, Beth Woods, Jean-Gabriel Castaigne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 8, 2012
Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis
Beth Woods, Neil Hawkins, William Dunlop, et al.
Lancet (London, England)
|
December 15, 2024
Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis
Huseyin Naci, Peter Murphy, Beth Woods, et al.
BMJ Global Health
|
December 14, 2021
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi
Laetitia Schmitt, Jessica Ochalek, Karl Claxton, et al.
Research Synthesis Methods
|
February 2, 2026
Methods for information-sharing in network meta-analysis: Implications for inference and policy
Georgios F Nikolaidis, Beth Woods, Stephen Palmer, et al.
Lancet (London, England)
|
June 28, 2025
Population health impact of NICE-recommended new drugs - Authors' reply
Huseyin Naci, Peter Murphy, Beth Woods, et al.
Applied Health Economics and Health Policy
|
May 9, 2025
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions
Kristina Aluzaite, Marta O Soares, Catherine Hewitt, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Lung Cancer (Amsterdam, Netherlands)
|
September 23, 2011
Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma
Beth Woods, Noman Paracha, David A Scott, et al.
BMC Medical Research Methodology
|
May 23, 2021
Classifying information-sharing methods
Georgios F Nikolaidis, Beth Woods, Stephen Palmer, et al.
Health Economics
|
January 16, 2024
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required
Beth Woods, James Lomas, Mark Sculpher, et al.
Journal of Medical Economics
|
December 7, 2013
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales
Sarah Dewilde, Beth Woods, Jean-Gabriel Castaigne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 8, 2012
Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis
Beth Woods, Neil Hawkins, William Dunlop, et al.
Lancet (London, England)
|
December 15, 2024
Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis
Huseyin Naci, Peter Murphy, Beth Woods, et al.
BMJ Global Health
|
December 14, 2021
Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi
Laetitia Schmitt, Jessica Ochalek, Karl Claxton, et al.
Research Synthesis Methods
|
February 2, 2026
Methods for information-sharing in network meta-analysis: Implications for inference and policy
Georgios F Nikolaidis, Beth Woods, Stephen Palmer, et al.
Lancet (London, England)
|
June 28, 2025
Population health impact of NICE-recommended new drugs - Authors' reply
Huseyin Naci, Peter Murphy, Beth Woods, et al.
Applied Health Economics and Health Policy
|
May 9, 2025
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions
Kristina Aluzaite, Marta O Soares, Catherine Hewitt, et al.
Page
of 5